Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort

Xiaoqin Liu1, Esben Agerbo2,3,4, Katja G Ingstrup2

  • 1National Center for Register-based Research, Aarhus University, Aarhus, Denmark lxq@econ.au.dk.

BMJ (Clinical Research Ed.)
|September 8, 2017
PubMed

Insights

In utero antidepressant exposure is linked to a higher risk of psychiatric disorders in children. This association may be influenced by maternal health conditions, not just the medication itself.

Area of Science:

  • Perinatal psychiatry
  • Developmental psychology
  • Epidemiology

Background:

  • Maternal antidepressant use during pregnancy is common.
  • Understanding the long-term effects on offspring is crucial for informed clinical decisions.
  • Previous studies have shown mixed results regarding the association between prenatal antidepressant exposure and child psychiatric disorders.

Purpose of the Study:

  • To investigate the association between antidepressant exposure in utero and the risk of psychiatric disorders in children.
  • To differentiate risks based on patterns of antidepressant use (continuation, discontinuation, new use).
  • To explore potential confounding factors, such as maternal psychiatric disorder severity.

Main Methods:

  • Population-based cohort study utilizing Danish national registers.
  • Inclusion of over 900,000 liveborn singletons born between 1998 and 2012.
  • Follow-up until July 2014 to ascertain first psychiatric diagnosis, with Cox regression models for hazard ratio estimation.

Main Results:

  • Overall psychiatric disorder incidence was higher in children exposed to antidepressants in utero compared to unexposed.
  • The highest incidence was observed in the 'new user' group (14.5%), followed by the 'continuation' group (13.6%).
  • Antidepressant continuation during pregnancy showed a significantly increased risk (HR 1.27) compared to discontinuation.

Conclusions:

  • In utero antidepressant exposure is associated with an elevated risk of psychiatric disorders in offspring.
  • The observed association may be influenced by the severity of maternal psychiatric disorders, in addition to prenatal drug exposure.
  • Future research should consider a broader spectrum of psychiatric outcomes and maternal factors.

Related Concept Videos

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.8K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.0K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.7K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
770
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
729